3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid TumorsAdvanced Solid TumorsRecruitingPhase 1 / Phase 22026-09-01NCT07700160
A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IMV101 as a Single Agent in Subjects With Relapsed/Refractory B-cell Non-Hodgkin LymphomaB-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmRecruitingEarly phase 12026-03-30NCT07376642
Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis CardiomyopathyTransthyroxin Amyloidosis CardiomyopathyRecruitingEarly phase 12025-02-14NCT06082050